SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.113
EU - Europa 5.037
AS - Asia 3.987
SA - Sud America 724
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 13
Totale 14.967
Nazione #
US - Stati Uniti d'America 4.997
SG - Singapore 1.543
IE - Irlanda 1.390
CN - Cina 1.080
RU - Federazione Russa 910
HK - Hong Kong 668
SE - Svezia 652
BR - Brasile 574
UA - Ucraina 539
IT - Italia 471
FR - Francia 340
VN - Vietnam 266
DE - Germania 246
IN - India 146
FI - Finlandia 130
GB - Regno Unito 121
TR - Turchia 77
AR - Argentina 57
CA - Canada 48
CZ - Repubblica Ceca 40
MX - Messico 40
PL - Polonia 34
NL - Olanda 32
IQ - Iraq 29
BD - Bangladesh 28
ZA - Sudafrica 27
AT - Austria 23
ES - Italia 22
VE - Venezuela 22
ID - Indonesia 21
EC - Ecuador 20
BE - Belgio 18
JP - Giappone 17
CL - Cile 14
AU - Australia 13
UZ - Uzbekistan 13
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
EU - Europa 11
GR - Grecia 11
KE - Kenya 11
SA - Arabia Saudita 11
PK - Pakistan 10
CO - Colombia 9
EG - Egitto 9
LT - Lituania 9
PE - Perù 9
JO - Giordania 8
MA - Marocco 8
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
CH - Svizzera 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
LB - Libano 6
LV - Lettonia 6
AM - Armenia 5
DZ - Algeria 5
ET - Etiopia 5
IL - Israele 5
IR - Iran 5
AL - Albania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NO - Norvegia 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
Totale 14.955
Città #
Dublin 1.389
San Jose 998
Singapore 735
Hong Kong 668
Chandler 487
Nyköping 481
Ashburn 477
Jacksonville 363
Dallas 247
Dearborn 222
Beijing 218
New York 212
Santa Clara 212
Lauterbourg 172
Nanjing 168
Princeton 142
Moscow 141
Munich 113
The Dalles 101
Wilmington 91
Ho Chi Minh City 86
Nanchang 78
Helsinki 68
Los Angeles 66
São Paulo 62
Shenyang 53
San Mateo 52
Hanoi 49
Rome 45
Bari 41
Ann Arbor 40
Boardman 38
Milan 32
Tianjin 28
Foggia 27
Hebei 27
Warsaw 27
Frankfurt am Main 25
London 25
Brno 24
Jiaxing 24
Shanghai 24
Kunming 23
Nuremberg 23
Pune 23
Brooklyn 22
Jinan 22
Rio de Janeiro 22
Guangzhou 21
Changsha 19
Des Moines 19
Hangzhou 19
Turku 19
Brussels 18
Seattle 18
Chicago 17
Belo Horizonte 16
Orem 16
San Francisco 16
Chennai 15
Tokyo 15
Council Bluffs 14
Haiphong 14
Montreal 13
Olomouc 13
Naples 12
Tashkent 12
Vienna 12
Baghdad 11
Brasília 11
Da Nang 11
Falkenstein 11
Hillsboro 11
Reading 11
Zhengzhou 11
Düsseldorf 10
Jakarta 10
Johannesburg 10
Taizhou 10
Toronto 10
Washington 10
Boston 9
Guayaquil 9
Ningbo 9
Norwalk 9
Porto Alegre 9
Thái Nguyên 9
Assago 8
Atlanta 8
Borås 8
Chengdu 8
Denver 8
Manchester 8
Mexico City 8
Phoenix 8
Redwood City 8
Woodbridge 8
Wuhan 8
Biên Hòa 7
Buenos Aires 7
Totale 9.324
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 219
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 216
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 195
A recurrent epidermoid cyst of the spleen: report of a case and literature review 176
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 166
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 155
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 154
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 152
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 148
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 147
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 144
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 143
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 141
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 138
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 136
Surgicel (R) granuloma mimicking ovarian cancer: A case report 135
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 134
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 132
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 132
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 131
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 131
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 130
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 129
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 127
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 127
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 125
Role of age in prostate and bladder cancer. A critical overview 125
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 124
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 123
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 122
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 122
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 122
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 122
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 121
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 119
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 119
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 116
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 110
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 110
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 109
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 109
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 109
Surgicel® granuloma mimicking ovarian cancer: A case report 108
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 108
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 106
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 106
Daily tadalafil for the chronic phase of stuttering priapism: A case report 106
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 104
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 104
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 104
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 103
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 102
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 101
p-NFkB expression in thyroid cancer. 100
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 99
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 97
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 97
Asymptomatic bladder metastasis from breast cancer. 96
Pilonidal cyst of the penis mimicking carcinoma. 95
N-cadherin up-regulation in aggressive oral squamous cell carcinoma. 94
Magnetic resonance imaging of penile paraffinoma: Case report 94
Molecular markers in bladder cancer: Novel research frontiers 94
Modulation of complement activation by pentraxin-3 in prostate cancer 94
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 94
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 94
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 94
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 92
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 92
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 91
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 89
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 89
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 88
Elderly patients and prostate biopsy. How old is too old? 87
Prostate cancer biomarkers: a practical review based on different clinical scenarios 87
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  87
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 86
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 86
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 86
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma 85
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 84
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 83
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 83
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 83
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 81
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 80
Micropapillary bladder cancer, a variant histology of the elderly 80
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 80
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 80
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 80
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 79
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 78
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 78
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience 78
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 76
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 73
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables 73
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 73
Assessing PD-L1 Expression in Different Tumor Types 71
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update 69
The broad landscape of follicular lymphoma: Part I 69
Totale 10.915
Categoria #
all - tutte 92.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.863


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 99 11 9
2021/2022806 59 12 38 12 45 9 93 60 101 150 27 200
2022/20233.001 262 181 146 107 144 230 10 222 1.532 44 55 68
2023/2024823 83 37 36 20 40 283 72 38 10 23 41 140
2024/20253.205 151 51 131 62 95 360 311 141 795 457 306 345
2025/20265.109 365 442 647 745 298 233 1.121 641 365 252 0 0
Totale 15.533